Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Depreciation and Depletion: 2010-2024

Historic Depreciation and Depletion for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to $1.5 million.

  • EyePoint Pharmaceuticals' Depreciation and Depletion rose 110.00% to $3,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $60,000, marking a year-over-year decrease of 57.14%. This contributed to the annual value of $1.5 million for FY2024, which is 208.00% up from last year.
  • EyePoint Pharmaceuticals' Depreciation and Depletion amounted to $1.5 million in FY2024, which was up 208.00% from $500,000 recorded in FY2023.
  • Over the past 5 years, EyePoint Pharmaceuticals' Depreciation and Depletion peaked at $1.5 million during FY2024, and registered a low of $189,000 during FY2020.
  • Moreover, its 3-year median value for Depreciation and Depletion was $500,000 (2023), whereas its average is $813,333.
  • Data for EyePoint Pharmaceuticals' Depreciation and Depletion shows a peak YoY surged of 208.00% (in 2024) over the last 5 years.
  • Over the past 5 years, EyePoint Pharmaceuticals' Depreciation and Depletion (Yearly) stood at $189,000 in 2020, then skyrocketed by 64.55% to $311,000 in 2021, then rose by 28.62% to $400,000 in 2022, then climbed by 25.00% to $500,000 in 2023, then soared by 208.00% to $1.5 million in 2024.